EQL Pharma shares rise 16% after a CFO's August purchase
- Insider
- Allan Sylvest Aasberg
- Role
- Chief financial officer
- Company
- EQL Pharma (EQL)
- Transaction
- Buy
- Shares
- 20,000
- Amount
- SEK 527K
- Price per share
- SEK 26.36
- Trade date
- Aug 14, 2026
- Filed
- Aug 19, 2026, 5 days after the trade
- Source
- Finansinspektionen ↗
EQL Pharma shares were up 16.3% today, at SEK 26.45 against a previous close of SEK 22.75. CFO Allan Sylvest Aasberg bought 20,000 shares at SEK 26.36 on Aug 14.
The purchase was worth SEK 527K and was filed on Aug 19, 5 days after the trade. Against the first close after the purchase, SEK 25.60 on Aug 17, the share is up 3.3%. It is the only disclosed buy in the last 90 days.
The price was recorded at 09:27 CET and is delayed by 15 to 20 minutes.
EQL +12.7% on the day, delayed quote Nov 5
Today+16.3%At 09:27 CET, delayed
PriceSEK 26.45Previous close SEK 22.75
Disclosed buys1In the last 90 days
Since purchase+3.3%Allan Sylvest Aasberg, Aug 14